CSIMarket
 


Onemednet Corporation  (ONMD)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

ONMD's Net Cash Flow Growth by Quarter and Year

Onemednet's Net Cash Flow results by quarter and year




ONMD Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.23 -0.08 -0.08 0.00
III Quarter September 0.00 -0.27 -0.27 0.00
II Quarter June -0.01 0.78 0.78 0.00
I Quarter March -0.02 0.03 0.03 0.00
FY   -0.26 0.46 0.46 0.00



ONMD Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Onemednet Corporation in the fourth quarter 2023 recorded net cash outflow of $ -0.23 millions.

According to the results reported in the fourth quarter 2023, Onemednet Corporation achieved the best Net Cash Flow growth in Medical Laboratories industry. While Onemednet Corporation' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




ONMD Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - 0 % - -
I Quarter March - 0 % - -
FY   - 0 % - -

Financial Statements
Onemednet's fourth quarter 2023 Net Cash Flow $ -0.23 millions ONMD's Income Statement
Onemednet's fourth quarter 2022 Net Cash Flow $ -0.08 millions Quarterly ONMD's Income Statement
New: More ONMD's historic Net Cash Flow Growth >>


ONMD Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - 2500 % 2500 % -
I Quarter March - - - -
FY (Year on Year)   - 0 % - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Onemednet's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ONMD's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ONMD's IV. Quarter Q/Q Net Cash Flow Comment


Onemednet's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -0.25 $ -0.11 $ -0.38 $ 0.41 $ 0.45
Y / Y Net Cash Flow Growth (TTM) - - - -10.1 % 0 %
Year on Year Net Cash Flow Growth Overall Ranking # # # # 362 # 405
Seqeuential Net Cash Flow Change (TTM) - - - -10.1 % 0 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 673 # 690 # 1014 # 362 # 405




Cumulative Net Cash Flow growth Comment
Onemednet Corporation realized trailing twelve months net cash outflow of $ 0 millions, in the Dec 31 2023, compare to Net Cash Flow of $ 0 millions a year ago.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 673, from total ranking in previous quarter at 690.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
-87.95 %
-183.06 %
(Dec 31 2022)  

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 80
Overall # 669

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
-87.95 %
-183.06 %
(Dec 31 2022)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 80
S&P 500 # 669
Cumulative Net Cash Flow growth Comment
Onemednet Corporation realized trailing twelve months net cash outflow of $ 0 millions, in the Dec 31 2023, compare to Net Cash Flow of $ 0 millions a year ago.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 673, from total ranking in previous quarter at 690.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
-87.95 %
-183.06 %
(Dec 31 2022)  


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 80
Overall # 669

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
-87.95 %
-183.06 %
(Dec 31 2022)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 80
S&P 500 # 669




Other Net Cash Flow Growth
Medical Laboratories Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
ONMD's Net Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for ONMD's Competitors
Net Cash Flow Growth for Onemednet's Suppliers
Net Cash Flow Growth for ONMD's Customers

You may also want to know
ONMD's Annual Growth Rates ONMD's Profitability Ratios ONMD's Asset Turnover Ratio ONMD's Dividend Growth
ONMD's Roe ONMD's Valuation Ratios ONMD's Financial Strength Ratios ONMD's Dividend Payout Ratio
ONMD's Roa ONMD's Inventory Turnover Ratio ONMD's Growth Rates ONMD's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Prenetics Global Limited315.60%$ 315.598 millions
Jazz Pharmaceuticals Plc305.04%$ 305.042 millions
Electromed Inc 274.31%$ 274.314 millions
Healthcare Services Group Inc 246.33%$ 246.329 millions
Morphosys Ag226.46%$ 226.456 millions
3m Company215.94%$ 215.936 millions
Artivion Inc 206.86%$ 206.858 millions
Envista Holdings Corporation201.56%$ 201.563 millions
Bristol myers Squibb Company188.82%$ 188.816 millions
Novocure Limited187.30%$ 187.300 millions
Alpha Pro Tech Ltd 186.55%$ 186.546 millions
Brainsway Ltd 181.19%$ 181.195 millions
Abeona Therapeutics Inc 180.17%$ 180.166 millions
Lemaitre Vascular Inc 179.96%$ 179.964 millions
Charles River Laboratories International inc 163.93%$ 163.925 millions
Stryker Corp162.03%$ 162.028 millions
Ptc Therapeutics inc 144.49%$ 144.492 millions
National Healthcare Corp114.37%$ 114.371 millions
Nature s Sunshine Products inc 107.91%$ 107.907 millions
Exact Sciences Corporation105.45%$ 105.454 millions
Cadre Holdings inc 104.55%$ 104.555 millions
Centogene N v 101.77%$ 101.768 millions
Amedisys Inc97.80%$ 97.799 millions
Mainz Biomed N v 96.41%$ 96.410 millions
Bausch Health Companies Inc 93.62%$ 93.617 millions
Galectin Therapeutics Inc 91.89%$ 91.887 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com